Literature DB >> 34021333

Durable mechanical circulatory support in patients with heart failure with preserved ejection fraction.

Pia Lanmueller1,2, Jaime-Juergen Eulert-Grehn1,2, Felix Schoenrath1,2, Burkert Pieske2,3,4, Johanna Mulzer1, Marcus Mueller1, Volkmar Falk1,2,4, Evgenij Potapov1,2.   

Abstract

Only few patients with heart failure with preserved ejection fraction undergo durable mechanical circulatory support implantation. We identified three patients with heart failure with preserved ejection fraction who needed durable mechanical circulatory support as bridge-to-transplant therapy. In two patients with hypertrophic cardiomyopathy, the hypertrophic papillary muscles and myocardium were resected to allow for subsequent left ventricular assist device implantation. In one patient, all visible parts of the mitral valve were additionally resected. The third patient with restrictive cardiomyopathy underwent Berlin Heart Excor BVAD implantation with left atrial cannulation.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Berlin Heart; Heart failure with preserved ejection fraction; LVAD

Mesh:

Year:  2021        PMID: 34021333      PMCID: PMC8691712          DOI: 10.1093/icvts/ivab144

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.

Authors:  Yan Topilsky; Naveen L Pereira; Dipesh K Shah; Barry Boilson; John A Schirger; Sudhir S Kushwaha; Lyle D Joyce; Soon J Park
Journal:  Circ Heart Fail       Date:  2011-02-08       Impact factor: 8.790

2.  HeartMate 3 implantation via left lateral thoracotomy with outflow graft anastomosis to the descending aorta.

Authors:  Antonia Schulz; Alexander Stepanenko; Thomas Krabatsch
Journal:  J Heart Lung Transplant       Date:  2016-01-15       Impact factor: 10.247

3.  Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.

Authors:  Avishay Grupper; Soon J Park; Naveen L Pereira; Sarah D Schettle; Yariv Gerber; Yan Topilsky; Brooks S Edwards; Richard C Daly; John M Stulak; Lyle D Joyce; Sudhir S Kushwaha
Journal:  J Heart Lung Transplant       Date:  2015-03-26       Impact factor: 10.247

4.  Mechanical circulatory support and heart transplantation.

Authors:  R Hetzer; E Hennig; A Schiessler; N Friedel; H Warnecke; M Adt
Journal:  J Heart Lung Transplant       Date:  1992 Jul-Aug       Impact factor: 10.247

5.  Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis.

Authors:  Snehal R Patel; Omar Saeed; David Naftel; Susan Myers; James Kirklin; Ulrich P Jorde; Daniel J Goldstein
Journal:  J Card Fail       Date:  2017-09-29       Impact factor: 5.712

  5 in total
  1 in total

Review 1.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.